CICONE, FRANCESCO

CICONE, FRANCESCO  

Dipartimento di Medicina sperimentale e clinica  

Mostra records
Risultati 1 - 20 di 89 (tempo di esecuzione: 0.056 secondi).
Titolo Data di pubblicazione Autore(i) File
"Boom-Boom" radioimmunotherapy of lymphomas: Are two magic bullets better than one? 1-gen-2016 Cicone, F.; Prior, J. O.; Scopinaro, F.
18 F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma 1-gen-2019 Cicone, F.; Carideo, L.; Scaringi, C.; Arcella, A.; Giangaspero, F.; Scopinaro, F.; Minniti, G.
18F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports 1-gen-2016 Cicone, F.; Clerico, A.; Minniti, G.; Paiano, M.; Carideo, L.; Scaringi, C.; Langen, K. -J.; Scopinaro, F.
18F-DOpA uptake parameters in glioma: Effects of patients’ characteristics and prior treatment history 1-gen-2018 Carideo, L.; Minniti, G.; Mamede, M.; Scaringi, C.; Russo, I.; Scopinaro, F.; Cicone, F.
18F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability 1-gen-2023 Pistone, Daniele; Gnesin, Silvano; Auditore, Lucrezia; Italiano, Antonio; Cascini, Giuseppe Lucio; Amato, Ernesto; Cicone, Francesco
A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures 1-gen-2018 Amato, E.; Cicone, F.; Auditore, L.; Baldari, S.; Prior, J. O.; Gnesin, S.
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) 1-gen-2010 Pacilio, M.; Betti, M.; Cicone, F.; Del Mastro, C.; Montani, L.; Chiacchiararelli, L.; Monaco, A.; Santini, E.; Scopinaro, F.
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery 1-gen-2015 Cicone, F.; Minniti, G.; Romano, A.; Papa, A.; Scaringi, C.; Tavanti, F.; Bozzao, A.; Maurizi Enrici, R.; Scopinaro, F.
Advanced imaging techniques for radiotherapy planning of gliomas 1-gen-2021 Castellano, A.; Bailo, M.; Cicone, F.; Carideo, L.; Quartuccio, N.; Mortini, P.; Falini, A.; Cascini, G. L.; Minniti, G.
Amino acid PET and MR perfusion imaging in brain tumours 1-gen-2017 Filss, C. P.; Cicone, F.; Shah, N. J.; Galldiks, N.; Langen, K. -J.
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia 1-gen-2013 Rigucci, S.; Rossi-Espagnet, C.; Ferracuti, S.; De Carolis, A.; Corigliano, V.; Carducci, F.; Mancinelli, I.; Cicone, F.; Tatarelli, R.; Bozzao, A.; Girardi, P.; Comparelli, A.
Cardiac radionuclide imaging in rodents: A review of methods, results, and factors at play 1-gen-2017 Cicone, F.; Viertl, D.; Quintela Pousa, A. M.; Denoel, T.; Gnesin, S.; Scopinaro, F.; Vozenin, M. -C.; Prior, J. O.
Central nervous system - Primary tumours 1-gen-2018 Cicone, Francesco; Prior, John O.
Central nervous system- Primary and secondary Tumours: Radiolabelled Amino Acids 1-gen-2018 Cicone, Francesco; Prior, John O.
Comment on hatzoglou et al: Dynamic contrastenhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury 1-gen-2017 Cicone, F.; Galldiks, N.; Minniti, G.; Filss, C. P.; Scopinaro, F.; Prior, J. O.; Albert, N. L.; Langen, K. -J.
Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules 1-gen-2022 Cicone, F.; Viertl, D.; Denoel, T.; Stabin, M. G.; Prior, J. O.; Gnesin, S.
Correction to: Preclinical Evaluation and Dosimetry of [111In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1) (Molecular Imaging and Biology, (2020), 22, 4, (979-991), 10.1007/s11307-020-01479-8) 1-gen-2020 Cicone, F.; Denoel, T.; Gnesin, S.; Riggi, N.; Irving, M.; Jakka, G.; Schaefer, N.; Viertl, D.; Coukos, G.; Prior, J. O.
Cross-sectional evaluation of FGD-avid polyostotic fibrous dysplasia: MRI, CT and PET/MRI findings 1-gen-2022 Pozzessere, Chiara; Cicone, Francesco; Barberio, Paolo; Papa, Annalisa; Coppolino, Giuseppe; Biagini, Roberto; Cascini, Giuseppe Lucio
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting 1-gen-2022 Cicone, F.; Sarnelli, A.; Guidi, C.; Belli, M. L.; Ferrari, M. E.; Wahl, R.; Cremonesi, M.; Paganelli, G.
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization 1-gen-2021 Cicone, Francesco; Gnesin, Silvano; Cremonesi, Marta